BDHCX
Price
$9.08
Change
+$0.01 (+0.11%)
Updated
Jun 2 closing price
Net Assets
1.6B
CIMCX
Price
$27.40
Change
+$0.08 (+0.29%)
Updated
Jun 2 closing price
Net Assets
146.54B
Interact to see
Advertisement

BDHCX vs CIMCX

Header iconBDHCX vs CIMCX Comparison
Open Charts BDHCX vs CIMCXBanner chart's image
BDHCX vs CIMCX Comparison Chart in %
View a ticker or compare two or three
VS
BDHCX vs. CIMCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDHCX is a Buy and CIMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 147B vs. BDHCX (1.6B). BDHCX pays higher dividends than CIMCX: BDHCX (6.63) vs CIMCX (2.73). BDHCX was incepted earlier than CIMCX: BDHCX (12 years) vs CIMCX (24 years). BDHCX (1.86) is less costly to investors than CIMCX (1.35). BDHCX is a more actively managed with annual turnover of: 148.00 vs. CIMCX (65.00). CIMCX has a lower initial minimum investment than BDHCX: CIMCX (250) vs BDHCX (1000). BDHCX annual gain was more profitable for investors over the last year : 12.47 vs. CIMCX (8.06). CIMCX return over 5 years is better than : 20.12 vs. BDHCX (18.85).
BDHCXCIMCXBDHCX / CIMCX
Total Expense Ratio1.681.35124%
Annual Report Gross Expense Ratio1.861.35138%
Fund Existence12 years24 years-
Gain YTD4.5555.65481%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.6B147B1%
Annual Yield % from dividends6.632.73243%
Returns for 1 year12.478.06155%
Returns for 3 years36.9533.07112%
Returns for 5 years18.8520.1294%
Returns for 10 years70.2667.70104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLCAX23.77N/A
N/A
JPMorgan US Large Cap Core Plus A
OINCX25.45N/A
N/A
JPMorgan Equity Income C
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
MXNSX22.96N/A
N/A
Empower S&P SmallCap 600® Index L
RYCFX45.37N/A
N/A
Rydex Biotechnology C